US 7601516
Heterodimeric follicle stimulating hormone-Fc (FSH-Fc) fusion proteins for the treatment of infertility
granted A61KA61K38/00A61P
Quick answer
US patent 7601516 (Heterodimeric follicle stimulating hormone-Fc (FSH-Fc) fusion proteins for the treatment of infertility) held by Syntonix Pharmaceuticals, Inc. expires Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Syntonix Pharmaceuticals, Inc.
- Grant date
- Tue Oct 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K38/00, A61P, A61P15/08, A61P5/10